Literature DB >> 9132027

Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.

L M Helms1, J P Felix, R M Bugianesi, M L Garcia, S Stevens, R J Leonard, H G Knaus, R Koch, S G Wanner, G J Kaczorowski, R S Slaughter.   

Abstract

Voltage-gated potassium (K(V)) channels play key roles in setting the resting potential and in the activation cascade of human peripheral T lymphocytes. Margatoxin (MgTX), a 39-amino acid peptide from Centruroides margaritatus, is a potent inhibitor of lymphocyte K(V) channels. The binding of monoiodotyrosinyl margatoxin ([125I]MgTX) to plasma membranes prepared from either Jurkat cells, a human leukemic T cell line, or CHO cells stably transfected with the Shaker-type voltage-gated K+ channel, K(V)1.3, has been used to investigate the properties of lymphocyte K(V) channels. These data were compared with [125I]MgTX binding to heterotetrameric K(V) channels in rat brain synaptic plasma membranes [Knaus, H. G., et al. (1995) Biochemistry 34, 13627-13634]. The affinity for [125I]MgTX is 100-200 fM in either Jurkat or CHO/K(V)1.3 membranes, and the receptor density is 20-120 fmol/mg in Jurkat membranes or 1000 fmol/mg in CHO/K(V)1.3 membranes. In contrast to rat brain, [125I]MgTX binding to Jurkat and CHO/K(V)1.3 membranes exhibits an absolute requirement for K+, with no potentiation of binding by Na+. K(V)1.3 was the only K(V)1 series channel present in either CHO/K(V)1.3 or Jurkat plasma membranes as determined by immunoprecipitation of [125I]MgTX binding or by Western blot analyses using sequence-specific antibodies prepared against members of the K(V)1 family. The relative potencies of a series of peptidyl K(V) channel inhibitors was essentially the same for inhibition of [125I]MgTX binding to Jurkat, CHO, or rat brain membranes and for blocking 86Rb+ efflux from the CHO/K(V)1.3 cells, except that alpha-dendrotoxin was more potent at blocking binding to rat brain membranes than in the other assays. The characteristics of [125I]MgTX binding, the antibody profiles, and the effects of the peptidyl K(V) inhibitors all indicate that the [125I]MgTX receptor in Jurkat lymphocytes is comprised of a homomultimer of K(V)1.3, unlike the heteromultimeric arrangement of the receptor in rat brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9132027     DOI: 10.1021/bi962351p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism.

Authors:  Itaru Watanabe; Hong-Gang Wang; Jhon J Sutachan; Jing Zhu; Esperanza Recio-Pinto; William B Thornhill
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

2.  A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Authors:  Kamilla Angelo; Yuliya V Korolkova; Morten Grunnet; Eugene V Grishin; Kirill A Pluzhnikov; Dan A Klaerke; Hans-Günther Knaus; Morten Møller; Søren-Peter Olesen
Journal:  Pflugers Arch       Date:  2003-08-05       Impact factor: 3.657

Review 3.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

4.  Kv1.3 channels regulate synaptic transmission in the nucleus of solitary tract.

Authors:  Angelina Ramirez-Navarro; Patricia A Glazebrook; Michelle Kane-Sutton; Caroline Padro; David D Kline; Diana L Kunze
Journal:  J Neurophysiol       Date:  2011-03-23       Impact factor: 2.714

5.  Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Authors:  Izumi Maezawa; Hai M Nguyen; Jacopo Di Lucente; David Paul Jenkins; Vikrant Singh; Silvia Hilt; Kyoungmi Kim; Srikant Rangaraju; Allan I Levey; Heike Wulff; Lee-Way Jin
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

6.  Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.

Authors:  Alexey I Kuzmenkov; Alexander A Vassilevski; Kseniya S Kudryashova; Oksana V Nekrasova; Steve Peigneur; Jan Tytgat; Alexey V Feofanov; Mikhail P Kirpichnikov; Eugene V Grishin
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

Review 7.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

8.  The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo.

Authors:  Jacopo Di Lucente; Hai M Nguyen; Heike Wulff; Lee-Way Jin; Izumi Maezawa
Journal:  Glia       Date:  2018-07-25       Impact factor: 7.452

Review 9.  Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells.

Authors:  T Bose; A Cieślar-Pobuda; E Wiechec
Journal:  Cell Death Dis       Date:  2015-02-19       Impact factor: 8.469

10.  A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3.

Authors:  Janna Bednenko; Rian Harriman; Lore Mariën; Hai M Nguyen; Alka Agrawal; Ashot Papoyan; Yelena Bisharyan; Joanna Cardarelli; Donna Cassidy-Hanley; Ted Clark; Darlene Pedersen; Yasmina Abdiche; William Harriman; Bas van der Woning; Hans de Haard; Ellen Collarini; Heike Wulff; Paul Colussi
Journal:  MAbs       Date:  2018-04-02       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.